A detailed history of Cubist Systematic Strategies, LLC transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 15,762 shares of VIGL stock, worth $25,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,762
Previous 3,653 331.48%
Holding current value
$25,692
Previous $14,000 278.57%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.92 - $4.65 $35,358 - $56,306
12,109 Added 331.48%
15,762 $53,000
Q2 2024

Aug 14, 2024

BUY
$2.51 - $4.66 $9,169 - $17,022
3,653 New
3,653 $14,000
Q2 2022

Aug 15, 2022

BUY
$2.23 - $7.81 $263 - $921
118 Added 11.8%
1,118 $3,000
Q1 2022

May 16, 2022

BUY
$7.03 - $17.29 $7,030 - $17,290
1,000 New
1,000 $7,000

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $46.1M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.